I should temper my excitment with this news by saying.
This new delivery method will ALLOW GSK to increase to 160 million packs PA which is quite likely given Tamiflu issues and huge relenza demand.
I would think the device will be a capsule or maybe a asthma like inhaler. Hope we know offically, sooner rather than later.